SYRESpyre Therapeutics, Inc.

$85.70+476% 1Y

Is the price fair?

What SYRE's price assumes

Price / book
2.29

Price / book · as of 2024-Q4

Details›
Price / bookas of 2024-Q4
2.29
Market capitalisation
$7.70B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks